(Q45862083)

17 December 2017

title

A novel PPAR gamma gene therapy to control inflammation associated with inflammatory bowel disease in a murine model (English)

1 reference

17 December 2017

inflammatory bowel diseases

main subject

gene therapy

0 references

inflammation

0 references

1 reference

1 reference

4

Hiroyuki Mizuguchi

1 reference

17 December 2017

3

Atsushi Nakajima

1 reference

17 December 2017

author name string

Kazufumi Katayama

1

1 reference

17 December 2017

Koichiro Wada

2

1 reference

17 December 2017

Takao Hayakawa

5

1 reference

17 December 2017

Shinsaku Nakagawa

6

1 reference

17 December 2017

Takashi Kadowaki

7

1 reference

17 December 2017

Ryozo Nagai

8

1 reference

17 December 2017

Yoshinori Kamisaki

9

1 reference

17 December 2017

Richard S Blumberg

10

1 reference

17 December 2017

Tadanori Mayumi

11

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

17 December 2017

published in

Gastroenterology

1 reference

17 December 2017

volume

124

1 reference

17 December 2017

issue

5

1 reference

17 December 2017

page(s)

1315-1324

1 reference

17 December 2017

Prospects for research in inflammatory bowel disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900262-2

Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900262-2

Low-Dose Cyclosporine for the Treatment of Crohn's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900262-2

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900262-2

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900262-2

Roles of PPARs in health and disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900262-2

Adipogenesis and obesity: rounding out the big picture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900262-2

Medical significance of peroxisome proliferator-activated receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900262-2

Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900262-2

A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900262-2

Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900262-2

PPARgamma and inflammatory bowel disease: a new therapeutic target for ulcerative colitis and Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900262-2

Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900262-2

Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900262-2

Activators of the nuclear receptor PPARgamma enhance colon polyp formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900262-2

Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900262-2

The use of adenoviral vectors for gene therapy and gene transfer in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900262-2

A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900262-2

A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900262-2

Efficient gene delivery into dendritic cells by fiber-mutant adenovirus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900262-2

Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900262-2

A simple and efficient method for purification of infectious recombinant adenovirus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900262-2

IL-15-dependent activation-induced cell death-resistant Th1 type CD8 alpha beta+NK1.1+ T cells for the development of small intestinal inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900262-2

Quantitative real-time PCR for equine cytokine mRNA in nondecalcified bone tissue embedded in methyl methacrylate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900262-2

Increased sensitivity to dextran sodium sulfate colitis in IRE1beta-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900262-2

Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900262-2

Interferon-gamma-mediated activation and ubiquitin-proteasome-dependent degradation of PPARgamma in adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900262-2

Gene expression profile after peroxisome proliferator activator receptor-gamma ligand administration in dextran sodium sulfate mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900262-2

15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900262-2

PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900262-2

10.1016/S0016-5085(03)00262-2

7 January 2021

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017